QPBE
Quintet Private Bank (Europe) Portfolio holdings
AUM
$1.73B
This Quarter Return
+10.58%
1 Year Return
+18.27%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.61B
AUM Growth
+$1.61B
(+7.3%)
Cap. Flow
-$38.8M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
53.33%
Holding
243
New
5
Increased
39
Reduced
99
Closed
47
Top Buys
| 1 |
Merck
MRK
|
$16.5M |
| 2 |
Procter & Gamble
PG
|
$12.2M |
| 3 |
Chevron
CVX
|
$5.74M |
| 4 |
Enphase Energy
ENPH
|
$4.43M |
| 5 |
Otis Worldwide
OTIS
|
$4.41M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$17.2M |
| 2 |
Starbucks
SBUX
|
$13M |
| 3 |
JPMorgan Chase
JPM
|
$11.4M |
| 4 |
Exxon Mobil
XOM
|
$9.71M |
| 5 |
NVIDIA
NVDA
|
$4.64M |
Sector Composition
| 1 | Technology | 34.33% |
| 2 | Communication Services | 14.23% |
| 3 | Healthcare | 14.16% |
| 4 | Financials | 12% |
| 5 | Consumer Staples | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Newmont
NEM
$81.7B
| $49.7K | ﹤0.01% |
1,200
| – | – |
|
152
Day One Biopharmaceuticals
DAWN
$769M
| $48.4K | ﹤0.01% |
3,313
+1,000
| +43% | +$14.6K |
|
153
VanEck Gold Miners ETF
GDX
$19B
| $46.5K | ﹤0.01% |
+1,500
| New | +$46.5K |
|
154
Apellis Pharmaceuticals
APLS
$3.48B
| $45K | ﹤0.01% |
752
| – | – |
|
155
SPDR S&P Metals & Mining ETF
XME
$2.31B
| $44.9K | ﹤0.01% |
+750
| New | +$44.9K |
|
156
FedEx
FDX
$54.5B
| $44.5K | ﹤0.01% |
176
| – | – |
|
157
BioNTech
BNTX
$24B
| $40.4K | ﹤0.01% |
385
-440
| -53% | -$46.2K |
|
158
FMC
FMC
$4.88B
| $31.4K | ﹤0.01% |
498
| – | – |
|
159
Oracle
ORCL
$635B
| $30.2K | ﹤0.01% |
286
| – | – |
|
160
Coherent
COHR
$14.1B
| $29.1K | ﹤0.01% |
667
-1
| -0.1% | -$44 |
|
161
General Dynamics
GD
$87.3B
| $26K | ﹤0.01% |
100
| – | – |
|
162
Enbridge
ENB
$105B
| $25.3K | ﹤0.01% |
700
-229
| -25% | -$8.28K |
|
163
Huntsman Corp
HUN
$1.94B
| $25.1K | ﹤0.01% |
1,000
| – | – |
|
164
Cintas
CTAS
$84.6B
| $24.1K | ﹤0.01% |
40
+20
| +100% | +$12.1K |
|
|
XIFR
165
XPLR Infrastructure, LP
XIFR
$996M
| $21.3K | ﹤0.01% |
699
-1
| -0.1% | -$30 |
|
166
Inspire Medical Systems
INSP
$2.77B
| $20.3K | ﹤0.01% |
100
| – | – |
|
167
Novartis
NVS
$245B
| $18.3K | ﹤0.01% |
181
-5,951
| -97% | -$601K |
|
168
Macy's
M
$3.59B
| $18.1K | ﹤0.01% |
900
| – | – |
|
169
iShares Select Dividend ETF
DVY
$20.8B
| $17.6K | ﹤0.01% |
150
| – | – |
|
170
iShares S&P 500 Value ETF
IVE
$41.2B
| $17.4K | ﹤0.01% |
100
| – | – |
|
171
iShares China Large-Cap ETF
FXI
$6.65B
| $13.7K | ﹤0.01% |
+570
| New | +$13.7K |
|
172
iShares S&P 500 Growth ETF
IVW
$63.1B
| $13.1K | ﹤0.01% |
175
| – | – |
|
173
Archer Aviation
ACHR
$5.77B
| $12.2K | ﹤0.01% |
1,985
+854
| +76% | +$5.24K |
|
174
Boston Scientific
BSX
$156B
| $11.6K | ﹤0.01% |
200
| – | – |
|
175
IHS Holding
IHS
$2.43B
| $11K | ﹤0.01% |
2,400
-1,950
| -45% | -$8.97K |
|